SMFS
VRCA icon

Squar Milner Financial Services’s Verrica Pharmaceuticals VRCA Stock Holding History

Squar Milner Financial Services’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-101
Closed -$10K – 709
2020
Q1 		$10K Hold
101
– – 0.01% 546
2019
Q4 		$15K Buy
+101
New +$14.9K 0.01% 554
2019
Q3 		– Sell
-101
Closed -$12K – 704
2019
Q2 		$12K Hold
101
– – 0.01% 508
2019
Q1 		$10K Hold
101
– – 0.01% 531
2018
Q4 		$8K Buy
101
+58
+135% +$7.04K 0.01% 513
2018
Q3 		$7K Buy
+43
New +$7.34K 0.01% 561

Other funds holding VRCA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Squar Milner Financial Services's VRCA Position: Q2 2020 in Review

Squar Milner Financial Services sold out of Verrica Pharmaceuticals (VRCA) in Q2 2020, closing a stake of 101 shares — an estimated $10K sold.

Squar Milner Financial Services first reported a position in VRCA in Q3 2018 and held it in 6 quarters. The position peaked at $15K in Q4 2019. 48 funds tracked by Wall St. Rank hold VRCA as of Q2 2020.

  • Squar Milner Financial Services reported no remaining Verrica Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Squar Milner Financial Services sold 101 Verrica Pharmaceuticals shares in Q2 2020, an estimated $10K.
  • Squar Milner Financial Services first reported a position in Verrica Pharmaceuticals in Q3 2018 and held it in 6 quarters.
  • Squar Milner Financial Services's Verrica Pharmaceuticals position peaked at $15K in Q4 2019.
  • 48 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2020.

Based on Squar Milner Financial Services's 13F filing for Q2 2020, filed 16 Jul 2020.